Bringing the fundamentals into focus…
Back to Rocket Pharmaceuticals, Inc.
How Rocket Pharmaceuticals, Inc. stacks up
RCKT · against 338 other Healthcare companies of similar size
Valuation
33/ 100
Below the middle of the pack.
Ranked #176 of 339 · scores higher than 42% of peers
Bars: peers in each 10-point band of the valuation score41 peers with a valuation score of 30–39, including RCKT · Click a bar to see the companies
Why valuation scores 33?
Weighted metrics compared with all Healthcare companies.Mainly because of its free cash flow yield and earnings yield, which are weaker than most Healthcare peers.
- Cash exceeds market value plus debt, so EBITDA yield is not meaningful and is left out.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -61.8% vs peer median 0.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -6.3% vs peer median 1.5%
Metric by metric
Position: dot = RCKT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RCKT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 323 reported | -6.8% | -0.3% | 36% | 30% | |
| EBITDA yieldHigher is better · 345 reported | -1354.2% | 1.9% | 2% | 50% | |
| Free cash flow yieldHigher is better · 176 reported | -61.8% | -9.3% | 7% | 20% | |
| Book yieldHigher is better · 330 reported | 134.1% | 52.1% | 86% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around RCKT| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 176 | 338M USD | 33 | ||
| 176 | 215M USD | 33 | 34 | |
| 176 | 239M USD | 33 | 38 | |
| 176 | 469M USD | 33 | 50 | |
| 176 | 276M USD | 33 | 46 | |
| 176 | 455M USD | 33 | 53 | |
| 176 | 149M USD | 33 | ||
| 176 | 191M USD | 33 | 38 | |
| 176 | 165M USD | 33 | 50 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score